NBIX
Neurocrine Biosciences
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: NBIX
- PEG Ratio
Based on the most recent data from Nov 11, 2026, NBIX's PEG ratio comes in at 0.41. This metric factors in a PE of 25.02 with an earnings growth rate of 61.7%. Relative to the 0.36 average from the previous four quarters, the PEG ratio has grown by 15%.
NBIX PEG ratio history
Looking at the last nine years, NBIX's PEG ratio has has been around 2.23 on average. At 0.41, today's PE to growth ratio sits 82% below its historical average. Within the last nine years, the Jun 2025 quarter recorded the highest PEG value at 24.08. At 0.02, the Dec 2020 quarter showed the minimum PEG ratio in this period.
Neurocrine Biosciences PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.71 | 29.49 | 41.5% |
| 2024 | 1.22 | 40.15 | 32.8% |
| 2023 | 0.87 | 51.47 | 59% |
| 2022 | 1.07 | 74.19 | 69.5% |
| 2021 | N/A | 89.65 | -78.3% |
| 2020 | 0.02 | 21.88 | 995% |
| 2019 | 3.64 | 268.73 | 73.9% |
| 2018 | 2.72 | 310.48 | 114.2% |
| 2017 | N/A | N/A | 0.6% |
| 2016 | N/A | N/A | -55.2% |
| 2015 | N/A | N/A | -29.6% |
| 2014 | N/A | N/A | -17.4% |
| 2013 | N/A | N/A | -962.5% |
| 2012 | N/A | 93.5 | -88.2% |
| 2011 | 0.02 | 12.5 | 553.3% |
Neurocrine Biosciences PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Sep 2026 | 0.33 | 20.35 | 61.7% |
| Jun 2026 | 0.23 | 23.91 | 102.6% |
| Mar 2026 | 0.16 | 19.63 | 121.5% |
| Dec 2025 | 0.71 | 29.49 | 41.5% |
| Sep 2025 | 2.78 | 32.57 | 11.7% |
| Jun 2025 | 24.08 | 36.12 | 1.5% |
| Mar 2025 | N/A | 36.5 | -19.6% |
| Dec 2024 | 1.22 | 40.15 | 32.8% |
| Sep 2024 | 0.31 | 29.85 | 96.9% |
| Jun 2024 | 0.46 | 40.14 | 87.4% |
| Mar 2024 | 0.08 | 36.58 | 462.7% |
| Dec 2023 | 0.87 | 51.47 | 59% |
| Sep 2023 | 0.26 | 57.4 | 221.3% |
| Jun 2023 | 0.04 | 51.53 | 1,307.7% |
| Mar 2023 | N/A | 151.07 | -11.8% |
NBIX average PEG ratio chart
Measured against past performance, NBIX's PEG ratio is below the 3, 5 and 10-year averages.
PEG comparison
Neurocrine Biosciences's PEG of 0.41 is above the industry average but below the Healthcare sector average. Compared to its Healthcare sector average of 0.62, Neurocrine Biosciences's PEG is 34% lower.
NBIX EPS growth
NBIX Price vs fair value
NBIX PEG vs peers
Compared to its peers, NBIX has a PEG ratio under stock LLY, while above ABBV's and ANIP's.
Frequently asked questions
What is Neurocrine Biosciences's PEG ratio?
According to Nov 11, 2026 data, NBIX's PEG ratio sits at 0.41.
What is the 3-year average PEG ratio for Neurocrine Biosciences (NBIX)?
NBIX's 3-year PEG ratio average stands at 2.84.
What is the 5-year average PEG ratio for Neurocrine Biosciences (NBIX)?
NBIX's 5-year PEG ratio average stands at 2.33.
What is the highest PEG ratio for NBIX?
NBIX's PEG ratio peaked at 24.08 during the Jun 2025 quarter - the highest in nine years.
How does the current PEG ratio for NBIX compare to its historical average?
NBIX currently has a PEG ratio 82% below its 9-year average.
Why is Neurocrine Biosciences's PEG ratio so low?
Rapid earnings growth combined with a reasonable valuation yields NBIX a PEG ratio of 0.41.
How is NBIX's PEG ratio calculated (Neurocrine Biosciences PEG ratio formula)?
PEG equals PE divided by EPS growth (YoY TTM). As of Nov 11, 2026, Neurocrine Biosciences has a P/E ratio of 25.02. Earnings grew at 61.7% over the TTM period ending Sep 2026. Applying the formula, this produces a price to earnings growth ratio of 0.41. PEG RATIO(0.41) = PE RATIO(25.02) / EPS GROWTH(61.7%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.